Does inhibition of apolipoprotein B synthesis produce foie gras?

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 877-878

  Feingold, Kenneth R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIPOMERSEN; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADD ON THERAPY; AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG TARGETING; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HUMAN; LIPID LIVER LEVEL; LIPOGENESIS; MONOTHERAPY; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; FATTY LIVER; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OLIGONUCLEOTIDES; PROTEIN BIOSYNTHESIS;

EID: 77951040555     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E005140     Document Type: Note

References (15)

1. Wiviott, S. D., and C. P. Cannon. 2006. The safety and effi cacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Curr. Opin. Lipidol. 17: 626-630.
2. Marks, D., M. Thorogood, H. A. Neil, and S. E. Humphries. 2003. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 168: 1-14. (Pubitemid 36559596)
3. LaRosa, J. C., S. M. Grundy, D. D. Waters, C. Shear, P. Barter, J. C. Fruchart, A. M. Gotto, H. Greten, J. J. Kastelein, and J. Shepherd, et al. 2005. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med. 352: 1425-1435.
4. Harper, C. R., and T. A. Jacobson. 2007. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr. Opin. Lipidol. 18: 401-408.
5. Akdim, F., E. S. Stroes, and J. J. Kastelein. 2007. Antisense apolipoprotein B therapy: where do we stand? Curr. Opin. Lipidol. 18: 397-400.
6. Burnett, J. R. 2006. Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia. Curr. Opin. Mol. Ther. 8: 461-467.
7. Visser, M. E., F. Akdim, D. L. Tribble, A. J. Nederveen, T. J. Kwoh, J. J. Kastelein, M. D. Trip, and E. S. Stroes. 2009. Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia. J. Lipid Res. 51: 1057-1062.
8. Kastelein, J. J., M. K. Wedel, B. F. Baker, J. Su, J. D. Bradley, R. Z. Yu, E. Chuang, M. J. Graham, and R. M. Crooke. 2006. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation. 114: 1729-1735.
9. Schonfeld, G., X. Lin, and P. Yue. 2005. Familial hypobetalipoproteinemia: genetics and metabolism. Cell. Mol. Life Sci. 62: 1372-1378.
10. Tanoli, T., P. Yue, D. Yablonskiy, and G. Schonfeld. 2004. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J. Lipid Res. 45: 941-947. (Pubitemid 38552865)
11. Sankatsing, R. R., S. W. Fouchier, S. de Haan, B. A. Hutten, E. de Groot, J. J. Kastelein, and E. S. Stroes. 2005. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler. Thromb. Vasc. Biol. 25: 1979-1984.
12. Cuchel, M., L. T. Bloedon, P. O. Szapary, D. M. Kolansky, M. L. Wolfe, A. Sarkis, J. S. Millar, K. Ikewaki, E. S. Siegelman, and R. E. Gregg, et al. 2007. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356: 148-156.
13. Chandler, C. E., D. E. Wilder, J. L. Pettini, Y. E. Savoy, S. F. Petras, G. Chang, J. Vincent, and H. J. Harwood, Jr. 2003. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J. Lipid Res. 44: 1887-1901.
14. Crooke, R. M., M. J. Graham, K. M. Lemonidis, C. P. Whipple, S. Koo, and R. J. Perera. 2005. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J. Lipid Res. 46: 872-884. (Pubitemid 43309212)
15. Koskinas, J., I. P. Gomatos, D. G. Tiniakos, N. Memos, M. Boutsikou, A. Garatzioti, A. Archimandritis, and A. Betrosian. 2008. Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J. Gastroenterol. 14: 1389-1393.